Skip to content

To evaluate periodontal inflamed surface area, serum Interleukin12, Interleukin18 levels in Stage III periodontitis patients with & without Type 2 Diabetes Mellitus

Evaluation of periodontal inflamed surface area, serum Interleukin-12, Interleukin-18 levels in Stage III periodontitis patients with and without Type 2 Diabetes Mellitus- A Cross Sectional Study

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
CTRI
Registry ID
CTRI/2023/06/053653
Enrollment
90
Registered
2023-06-08
Start date
Unknown
Completion date
Unknown
Last updated
2023-06-26

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: K053- Chronic periodontitis Health Condition 2: K053- Chronic periodontitis

Interventions

Control Intervention1: Nil: Nil

Sponsors

none
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Group I Periodontally healthy patients GI is equal to0 probing depth PPD less than or equal to 3 mm CAL is equal to 0 with no radiographic evidence of bone loss Group II Stage III periodontitis with GI greater than 1 PPD more than or equal to 6mm and CAL more than or equal to 5mm Group III Stage III periodontitis with T2DM patients GI more than 1 PPD more than or equal to 6mm and CAL more than or equal to 5mm HbA1c levels between 5 to 7 percent

Exclusion criteria

Exclusion criteria: Patients who have undergone any periodontal therapy in the past 6 months Patients with symptoms of acute illness Patients who are on immunosuppressive therapy Systemic anti inflammatory treatment within the previous 3 months or regular use of specific drugs known to affect periodontal tissues Pregnant women and lactating mothers

Design outcomes

Primary

MeasureTime frame
To evaluate the PISA, serum IL-12, IL-18 levels in Stage III periodontitis patients with & without T2DMTimepoint: At Baseline

Secondary

MeasureTime frame
To evaluate PISA, IL-12, IL-18 levels in periodontally healthy patients To evaluate & compare PISA, serum IL-12, IL-18 levels in patients with Stage III periodontitis with and without T2DM Timepoint: At Baseline

Countries

India

Contacts

Public ContactDr Abhay Kolte

104 Department of Periodontics and Implantology VSPM DCRC

drrajashrikolte@gmail.com9011071468

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Jun 10, 2026